Literature DB >> 10730516

Combined raw cornstarch and nifedipine as an additional treatment in persistent hyperinsulinemic hypoglycemia of infancy.

C Suprasongsin1, U Suthutvoravut, P Mahachoklertwattana, C Preeyasombat.   

Abstract

This study reports the result of treatment with the combination of raw cornstarch and nifedipine in two infants affected with hyperinsulinemic hypoglycemia of variable severity. The first infant developed hypoglycemia during early neonatal period and required subtotal pancreatectomy. She still developed hypoglycemia after her second operation. The second infant developed hypoglycemia at the age of 7 months. Raw cornstarch and nifedipine efficiently normalized both infants' blood glucose levels. Although they still need frequent feedings, no hypoglycemic episode was reported except when they were sick. Their growth and development were markedly improved after initiation of treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10730516

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  4 in total

Review 1.  Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies.

Authors:  Marzieh Salehi; Adrian Vella; Tracey McLaughlin; Mary-Elizabeth Patti
Journal:  J Clin Endocrinol Metab       Date:  2018-08-01       Impact factor: 5.958

Review 2.  The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia.

Authors:  Klára Roženková; Maria Güemes; Pratik Shah; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-06

Review 3.  Congenital Hyperinsulinism: Diagnosis and Treatment Update.

Authors:  Hüseyin Demirbilek; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27

Review 4.  Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers.

Authors:  Alena Welters; Christian Lerch; Sebastian Kummer; Jan Marquard; Burak Salgin; Ertan Mayatepek; Thomas Meissner
Journal:  Orphanet J Rare Dis       Date:  2015-11-25       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.